top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
mTOR Signaling in Metabolism and Cancer
mTOR Signaling in Metabolism and Cancer
Autore Huang Shile
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (204 p.)
Soggetto topico Medicine
Soggetto non controllato Acute Lymphoblastic leukemia
adhesion
Akt
basal cell carcinoma
biomarkers
cancers
cell metabolism
cell signalling
clinical trials
combination
eribulin
everolimus
Foxp3
head and neck cancer
hematologic malignancies
histone deacetylase
inhibitors
integrins
intestine
invasion
liver
melanoma
Merkel cell carcinoma
metabolism
mTOR
mTOR signaling
mTOR signalling
muscle
mutant genes
neuron
photodynamic therapy
phytochemicals
PI3K
PI3K/AKT/mTOR
prostate cancer
regulatory T cells
skin cancers
squamous cell carcinoma
synergy
T cells
targeted therapies
targeted therapy
tissue regeneration
TNBC
tumor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557107203321
Huang Shile  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (294 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acetyltransferase
AKT
antigen processing machinery (APM) molecules
AR
biomarker
biomarkers
bladder cancer
blood
BRCA1/2
breast cancer
cancer
cancer immunotherapy
cancer prognosis
carcinogenesis
cardioncology
cardiotoxicity
castration-resistant prostate cancer (CRPC)
CD8+ T effector cells
chemo-/radio resistance
CSC
CTCs
cytokines
EMT
eribulin
genetic syndromes
genomic mutations
head and neck cancer
head and neck neoplasms
head and neck tumors
HRR
HUB nodes
human leukocyte antigen (HLA)
hyperglycemia
immune checkpoint inhibitor
K-RAS oncogene
laryngeal cancer
lifestyle habit
major histocompatibility complex (MHC)
MAPK
melanoma
melanoma resistance to MAPK/MEK inhibitors
metabolomics
metastasis
microRNA
miRNA
MSI2
mTOR
musashi 2
mutations
N-cadherin
n/a
NAA10
new metastasis
nivolumab
oncogene dependency
oral cancer
OSCC
pancreatic cancer
paraganglioma
PDL1
pheochromocytoma
PI3K
PI3KCA
prediction
prognosis
prostate cancer
PTEN
resistance to immune checkpoint inhibitors
selenoproteins
targeted therapies
therapeutic resistance
therapeutic target
TILs
TNBC
transcriptomics
tumor predisposition
WNT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui